Healthy Clinical Trial
— AMPEDOfficial title:
Accelerating Motor Learning in Pediatrics
NCT number | NCT03193580 |
Other study ID # | REB16-2474 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 1, 2017 |
Est. completion date | August 30, 2018 |
Verified date | April 2019 |
Source | University of Calgary |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Non-invasive brain stimulation can both study and potentially treat neurological disorders.
Transcranial direct-current stimulation (tDCS) is an emerging safe and tolerability form of
stimulation and has been used increasingly over the last decade.
The purpose of this research is to see if two different types of tDCS can improve motor
function in healthy children. tDCS has been shown to safely enhance hand motor function in
healthy adults, and those that have suffered stroke and other conditions. Recently the
investigators demonstrated that tDCS may enhance hand motor function in healthy children,
however, how it does so is unknown. In addition to assessing changes in motor function when
tDCS is given during motor skill training, the investigators will perform various tests
before and after stimulation to understand the changes that happen in the brain accompanying
motor skill learning and brain stimulation.
The investigators hypothesize that there will be an accelerated acquisition of motor skill,
when training is paired with conventional anodal tDCS, HD-tDCS, or sham tDCS.
Status | Completed |
Enrollment | 24 |
Est. completion date | August 30, 2018 |
Est. primary completion date | July 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Age 12-18 years - Right-handed - Normal development - No neuropsychiatric disorders, neuropsychotropic medications, or chronic medical conditions - Informed consent/assent Exclusion Criteria: - Implanted electrical devices, including (but not limited to) cardiac pacemakers. - Metallic implants or irremovable metal objects - Pregnant females or females who may be pregnant. - Braces or upper teeth wires. |
Country | Name | City | State |
---|---|---|---|
Canada | Alberta Children's Hospital | Calgary | Alberta |
Canada | Alberta Childrens Hospital | Calgary | Alberta |
Lead Sponsor | Collaborator |
---|---|
University of Calgary |
Canada,
Ciechanski P, Kirton A. Transcranial Direct-Current Stimulation Can Enhance Motor Learning in Children. Cereb Cortex. 2017 May 1;27(5):2758-2767. doi: 10.1093/cercor/bhw114. — View Citation
Kirton A, Ciechanski P, Zewdie E, Andersen J, Nettel-Aguirre A, Carlson H, Carsolio L, Herrero M, Quigley J, Mineyko A, Hodge J, Hill M. Transcranial direct current stimulation for children with perinatal stroke and hemiparesis. Neurology. 2017 Jan 17;88(3):259-267. doi: 10.1212/WNL.0000000000003518. Epub 2016 Dec 7. — View Citation
Kuczynski AM, Dukelow SP, Semrau JA, Kirton A. Robotic Quantification of Position Sense in Children With Perinatal Stroke. Neurorehabil Neural Repair. 2016 Sep;30(8):762-72. doi: 10.1177/1545968315624781. Epub 2016 Jan 7. — View Citation
Kuczynski AM, Semrau JA, Kirton A, Dukelow SP. Kinesthetic deficits after perinatal stroke: robotic measurement in hemiparetic children. J Neuroeng Rehabil. 2017 Feb 15;14(1):13. doi: 10.1186/s12984-017-0221-6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Tolerability questionnaire | TMS and tDCS safety and tolerability. The questionnaire will be filled out after daily stimulation and at follow-up at 6 weeks. | Baseline, following stimulation daily, and 6 weeks following training | |
Primary | Change in Left Hand Purdue Pegboard Test Score | A "baseline" trial will be performed. Each day they will do 15 repetitions for 5 consecutive days. On the fifth day, they will do a post training trial consisting of 3 repetitions. | Baseline and immediately post-training on day 5 | |
Secondary | Percent change in metabolic markers | Metabolic markers including GABA and glutamate will be assessed using Magnetic Resonance Spectroscopy (MRS). An MRS will be performed at baseline, on day 5 post-training, and at the 6 week follow-up. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in functional motor activations | Measures of functional motor activity will be assessed using Functional Magnetic Resonance Imaging (MRI). Finger-tapping task will be performed in the MRI scanner. An MRI will be performed at baseline, on day 5 post-training, and at the 6 week follow-up. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in robotic sensorimotor measures | The Kinesiological Instrument for Normal and Altered Reaching Movements (KINARM). The raw change in measures of proprioception, kinesthesia, visually-guided reaching, and object hit tasks will be measured. On the fifth day, the participants will do a post-training trial. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in vibro-tactile sensory measures | The raw change of the Brain Gauge vibro-tactile sensory assessment score will be measured. On the fifth day, the participants will do a post-training trial. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in size of transcranial magnetic stimulation (TMS) motor maps | The raw change in TMS-measured motor evoked potential amplitude (Microvolts,uV) and neurophysiological changes in motor evoked potential size (Microvolts,uV). On the fifth day, the participants will do a post-training trial. Six weeks following the end of training, the participants will perform the task. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in motor function tasks - Serial Reaction Time test | Raw change in score on the Serial Reaction Time test. A "baseline" trial will be performed. On the fifth day, the participants will do a post-training trial. All tasks are measured in milliseconds. Six weeks following the end of training, the participants will perform the task. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in motor function tasks - Jebsen-Taylor test | Raw change in score on the Jebsen-Taylor test. A "baseline" trial will be performed. All measures are measured in seconds. On the fifth day, the participants will do a post-training trial. Six weeks following the end of training, the participants will perform the task. | Baseline, post-training on day 5, and 6 weeks following training | |
Secondary | Raw change in motor function tasks - Purdue Pegboard test | Raw change in score on the Purdue Pegboard Test for the left, right, and both hands. A "baseline" trial will be performed. The average number of pegs places will be measured. On the fifth day, they will do a post training trial consisting of 3 repetitions for the left, right, and both hands trials. Six weeks following the end of training, the participants will perform 3 repetitions for the left, right and both hands trials. | Baseline, post-training on day 5, and 6 weeks following training |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |